India
· Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 905.46 billion. The enterprise value is 905.71 billion.
| Market Cap | 905.46B |
| Enterprise Value | 905.71B |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | Jul 26, 2024 |
Share Statistics
NSE:ZYDUSLIFE has 1.01 billion shares outstanding. The number of shares has decreased by -0.46% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.01B |
| Shares Change (YoY) | -0.46% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 75.08% |
| Owned by Institutions (%) | 14.12% |
| Float | 249.06M |
Valuation Ratios
The trailing PE ratio is 20.00 and the forward PE ratio is 19.29. NSE:ZYDUSLIFE's PEG ratio is 1.84.
| PE Ratio | 20.00 |
| Forward PE | 19.29 |
| PS Ratio | 4.07 |
| PB Ratio | 4.15 |
| P/TBV Ratio | 6.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.84 |
Enterprise Valuation
| EV / Earnings | 19.96 |
| EV / Sales | 4.07 |
| EV / EBITDA | 14.34 |
| EV / EBIT | 16.31 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 63.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.04% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.26M |
| Profits Per Employee | 1.69M |
| Employee Count | 26,921 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.87% in the last 52 weeks. The beta is 0.47, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -7.87% |
| 50-Day Moving Average | 945.96 |
| 200-Day Moving Average | 1,041.97 |
| Relative Strength Index (RSI) | 45.68 |
| Average Volume (20 Days) | 1,150,152 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 222.47 billion and earned 45.37 billion in profits. Earnings per share was 45.03.
| Revenue | 222.47B |
| Gross Profit | 158.30B |
| Operating Income | 54.72B |
| Pretax Income | 59.82B |
| Net Income | 45.37B |
| EBITDA | 62.18B |
| EBIT | 54.72B |
| Earnings Per Share (EPS) | 45.03 |
Balance Sheet
The company has 24.95 billion in cash and 1.91 billion in debt, giving a net cash position of 23.05 billion or 22.90 per share.
| Cash & Cash Equivalents | 24.95B |
| Total Debt | 1.91B |
| Net Cash | 23.05B |
| Net Cash Per Share | 22.90 |
| Equity (Book Value) | 241.55B |
| Book Value Per Share | 217.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.15%, with operating and profit margins of 24.60% and 20.39%.
| Gross Margin | 71.15% |
| Operating Margin | 24.60% |
| Pretax Margin | 26.89% |
| Profit Margin | 20.39% |
| EBITDA Margin | 27.95% |
| EBIT Margin | 24.60% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.46% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 5.01% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |